Beschreibung
HieffTM LongSeq Plasmid Fragmentation and Ligation Module is a dedicated enzymatic module developed for third-generation Nanopore sequencing platforms. When used in combination with Cat. No. 13304ES, it enables streamlined plasmid library construction.
This kit is optimized specifically for plasmid DNA library preparation. Following enzymatic fragmentation, end repair, and dA-tailing, no purification step is required—samples can proceed directly to barcode ligation, significantly simplifying the workflow.
Features
- Wide input range: 50 ng – 1 µg plasmid DNA
- Fast workflow: ~2 hours from DNA to library
- Enzyme-based fragmentation: controlled, low-damage digestion
- Long-read friendly: preserves plasmid integrity and long inserts
- Consistent performance: strict batch-to-batch quality control
Components
|
Components NO. |
Name |
13305ES08 |
13305ES24 |
13305ES96 |
|
|
|
|
8 T |
24 T |
96 T |
|
|
13305-A |
|
80 μL |
240 μL |
960 μL |
|
|
13305-B |
|
SmearaseTM Enzyme |
40 μL |
120 μL |
480 μL |
|
13305-C |
|
Rapid Ligase Master Mix |
280 μL |
840 μL |
4×840 μL |
Storage
This product should be stored at -25~-15℃ for one year.
Figure
Excellent Nanopore sequencing performance

Sequencing Size Distribution

Figure 1. High-Quality Nanopore Sequencing of Plasmid Libraries Prepared Using Yeasen Enzymatic Fragmentation(13305ES+13304ES).
Plasmid libraries were prepared from 100–200 ng input DNA through a rapid 2-minute enzymatic fragmentation process. The resulting libraries achieved an N50 of 2–5 kb, showcasing robust and reproducible long-read sequencing performance on Oxford Nanopore platforms.
Documents:
Safety Data Sheet
Manuals
13305_Manual_Ver.EN20260302.pdf
Related Blog:
Full-Length Plasmid Sequencing Made Easy: Verify Your Plasmids with Co
Zahlung und Sicherheit
Ihre Zahlungsinformationen werden sicher verarbeitet. Wir speichern weder Kreditkartendaten noch Zugriff auf Ihre Kreditkarteninformationen.
Sie können auch mögen
Anfrage
FAQ
Das Produkt ist nur für Forschungszwecke bestimmt und nicht für die therapeutische oder diagnostische Anwendung bei Menschen oder Tieren. Produkte und Inhalte sind durch Patente, Marken und Urheberrechte von
Für bestimmte Anwendungen sind möglicherweise zusätzliche geistige Eigentumsrechte Dritter erforderlich.


